Kotra Industries Bhd
KLSE:KOTRA
Kotra Industries Bhd
Free Cash Flow
Kotra Industries Bhd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Free Cash Flow
myr19.7m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Free Cash Flow
myr1.7m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-3%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Free Cash Flow
-myr12m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Free Cash Flow
myr17.3m
|
CAGR 3-Years
155%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Free Cash Flow
myr40.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
23%
|
|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Free Cash Flow
myr64.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
Kotra Industries Bhd
Glance View
Kotra Industries Bhd.is an investment holding company, which engages in the manufacturing and trading of pharmaceutical and healthcare products. The company is headquartered in Malacca, Melaka and currently employs 660 full-time employees. The company went IPO on 2000-10-30. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd, is engaged in pharmaceutical and healthcare products manufacturing and trading business. Its segments include Malaysia, Asia and Africa. Its products include Appeton Multivitamin Pastilles, which is a healthy chewable pastille (non-sugar coated) for children; Axcel Glimepiride Medication, which is used to treat diabetes mellitus type 2; Axcel Bromhexine (Children) Syrup, which is a mucolytic medicine used in the treatment of respiratory chest congestion; Arite Beclometasone 50mcg (Metered Dose Inhaler Product), which is used in long-term management of asthma; Vaxcel Granisetron Injection, which is an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy, and Axcel Atenolol, which is used to treat high blood pressure and heart-associated chest pain.
See Also
What is Kotra Industries Bhd's Free Cash Flow?
Free Cash Flow
19.7m
MYR
Based on the financial report for Dec 31, 2024, Kotra Industries Bhd's Free Cash Flow amounts to 19.7m MYR.
What is Kotra Industries Bhd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
0%
Over the last year, the Free Cash Flow growth was -42%. The average annual Free Cash Flow growth rates for Kotra Industries Bhd have been -29% over the past three years , -5% over the past five years .
You don't have any saved screeners yet